Physician profile
Diane Schmidt
NPI 1689679763
$8,889.28
in general payments reported to CMS, 2019-2025
48 companies · $1,762 in 2025
The $1,762 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,345 · 2022: $1,874 · 2023: $1,681 · 2024: $2,228 · 2025: $1,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,560 · Travel and Lodging: $778 · Education: $221 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,560.44 |
| Travel and Lodging | $777.80 |
| Education | $220.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,154.75 | 2023-2024 | Interstim |
| Sumitomo Pharma America, INC. | $1,115.51 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $999.50 | 2021-2025 | Myrbetriq, Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $696.53 | 2022-2025 | |
| Abbvie INC. | $560.75 | 2021-2025 | |
| Janssen Biotech, INC. | $541.25 | 2021-2025 | Erleada, Akeega |
| Urovant Sciences INC | $369.66 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $314.28 | 2021-2024 | Aveed, Xiaflex |
| Boston Scientific Corporation | $301.26 | 2021-2023 | Ams 700 Cxr Rte Kit, Greenlight Xps |
| Pfizer INC. | $277.30 | 2021-2025 | |
| Myovant Sciences INC. | $225.61 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $224.84 | 2022-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $218.64 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Dendreon Pharmaceuticals LLC | $185.71 | 2021-2025 | Provenge |
| Tempus Ai, INC | $169.32 | 2024 | Xt Cdx |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $160.83 | 2021-2022 | |
| Antares Pharma, INC. | $159.20 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Tolmar, INC. | $135.10 | 2023-2025 | Eligard, Jatenzo |
| Mission Pharmacal Company | $130.20 | 2022-2023 | Uribel |
| Urogen Pharma, INC. | $93.86 | 2024-2025 | |
| Amgen INC. | $81.15 | 2021-2023 | Xgeva, Vectibix, Nplate |
| Coloplast Corp | $72.04 | 2023-2025 | Speedicath |
| Endo USA, INC. | $68.98 | 2024-2025 | Xiaflex, Aveed |
| Olympus America INC. | $46.63 | 2023-2024 | Itind System |
| Accord Healthcare, INC. | $45.22 | 2025 | |
| Bioprotect Medical, INC. | $40.76 | 2025 | Bioprotect Balloon Implant System |
| Convatec INC. | $40.69 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $38.06 | 2025 | |
| Alnylam Pharmaceuticals INC. | $37.24 | 2022-2025 | Givlaari |
| Ferring Pharmaceuticals INC. | $34.90 | 2024-2025 | Adstiladrin |
| Axonics, INC. | $29.07 | 2023 | Axonics |
| Novartis Pharmaceuticals Corporation | $28.36 | 2025 | |
| Laborie Medical Technologies Corp. | $26.92 | 2025 | Endosheath Technology |
| Allergan, INC. | $26.73 | 2022 | |
| Clovis Oncology, INC. | $24.03 | 2021 | |
| Janssen Pharmaceuticals, INC | $22.00 | 2025 | Erleada |
| Civco Medical Instruments | $20.05 | 2024 | |
| Caris Mpi, INC. | $19.86 | 2025 | Mi Cancer Seek |
| Blue Earth Diagnostics | $19.59 | 2021 | |
| Avyxa Pharma, LLC | $18.92 | 2025 | |
| Myriad Genetic Laboratories, INC. | $17.89 | 2021 | |
| Valencia Technologies Corporation | $15.42 | 2025 | Ecoin Device Kit |
| Sun Pharmaceutical Industries INC. | $14.25 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $13.95 | 2021 | |
| Teleflex LLC | $13.87 | 2024 | Solesta |
| Foundation Medicine, INC. | $13.66 | 2022 | |
| Millicent US INC | $13.03 | 2023 | Intrarosa, Femring |
| 180 Medical, INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.